What You Need to Know About PAH and Scleroderma

Recent Posts

• National Scleroderma Foundation recognizes outstanding chapters
• Developing a plan is helpful when dealing with medical uncertainty
• SRF joins capital effort to advance drug development for scleroderma
• Scientists ID 4 SSc-ILD subtypes to better predict patient outcomes
• Phase 2 trial testing nemolizumab for SSc slated to launch soon
• Immune cells linked to kidney, lung complications in SSc: Study
• Why scleroderma awareness is important to me
• CAR T-cell therapy rese-cel shows early efficacy in systemic sclerosis
• Pulmonary hypertension may be scleroderma marker of prognosis
• Scleroderma community gears up for awareness month in June